Giorgos Takousiis

Giorgos Takousiis is an experienced professional in the pharmaceutical and biotech sectors, currently serving as Associate Manager for Portfolio & Commercial Development at Xellia Pharmaceuticals since October 2023. In this role, Giorgos focuses on commercial development, portfolio management, and market insights using various analytical tools. Prior experience includes serving as a Regulatory Intelligence Analyst at Epoqe Pharma ApS, where Giorgos analyzed clinical trial guidelines, and as a Market Strategy Analyst at Eurofins BioPharma, where new market strategies were developed. Additional roles include Project Manager at Antibody Design and Scientific Researcher at the Institute of Molecular Biology and Biotechnology, complemented by teaching responsibilities. Giorgos holds a Master of Science in Business Administration and Bioentrepreneurship from Copenhagen Business School, a Master's degree in Biology-Biotechnology from the University of Copenhagen, and a Bachelor's degree in Biology with a specialization in Biomolecular Sciences and Biotechnology from the University of Crete.